GSK, GB00BN7SWP63

GSK stock pre-market at EUR 20.70

Published on 10/12/2026 at 08:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At Lang & Schwarz, GSK is quoted at EUR 20.70 in pre-market trading on October 12, 2026. Pennsylvania said the company plans to invest more than $800 million in an expansion.

Key points in brief

  • GSK stock is at EUR 20.70 in pre-market trading at Lang & Schwarz.
  • Pennsylvania announced an investment of more than $800 million from GSK on October 9, 2026.
  • The Upper Merion expansion is planned to create more than 300 jobs over five years.
Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht
GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK stock is at EUR 20.70 in pre-market trading at Lang & Schwarz on October 12, 2026, at 8:07 a.m. CEST.

Pre-market price

The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of GSK stock.

Pennsylvania expansion

On October 9, 2026, the Commonwealth of Pennsylvania said GSK will invest more than $800 million to expand its operations in Montgomery County. The project in Upper Merion Township is planned to create more than 300 new jobs over the next five years and retain approximately 4,500 existing full-time positions across the state, according to the Commonwealth of Pennsylvania.

Construction is planned to begin in 2027. The expansion is to include a commercial-scale biologics manufacturing facility, a research and development pilot plant, a centralized quality-control laboratory and a manufacturing science and technology hub, the state said.

Market context: Market report FTSE 100.

More news and analysis on GSK stock

Disclaimer...

en | GB00BN7SWP63 | GSK | boerse | 70296765 | bgmi